骨关节结核局部药物缓释材料研究进展

中国防痨杂志 ›› 2013, Vol. 35 ›› Issue (5): 376-378.

骨关节结核局部药物缓释材料研究进展

李大伟马远征

100091 北京，解放军第三Ｏ九医院全军骨科中心

收稿日期:2013-02-19 出版日期:2013-05-10 发布日期:2013-07-02
通信作者: 马远征 E-mail:myzzxq@sina.com

Research progresses of drug delivery material in the treatment of osteoarticular tuberculosis

LI Da-wei, MA Yuan-zheng

Orthopaedics Center, the 309th Hospital of Chinese People’s Liberation Army, Beijing 100091, China

Received:2013-02-19 Online:2013-05-10 Published:2013-07-02
Contact: MA Yuan-zheng E-mail:myzzxq@sina.com

摘要/Abstract

摘要： 抗结核药物缓释材料是近些年骨关节结核治疗领域的新热点，材料在植入骨关节结核病灶内后，作为骨替代物修复骨缺损的同时，能够长时间释放抗结核药物。笔者简要综述了骨关节结核局部药物缓释材料的相关研究进展。

关键词: 结核,骨关节, 药物释放系统, 生物相容性材料

Abstract: Antituberculosis drug delivery material is a new focus in the field of osteoarticular tuberculosis treatment.The material implanted in osteoarticular tuberculosis lesions can repair the bone defect and release antituberculosis drug in a long time. In this article, the recent progresses in research on drug delivery material in the treatment of osteoarticular tuberculosis have been reviewed.

Key words: Tuberculosis,osteoarticular, Drug delivery systems, Biocompatible materials

李大伟马远征. 骨关节结核局部药物缓释材料研究进展[J]. 中国防痨杂志, 2013, 35(5): 376-378.

LI Da-wei, MA Yuan-zheng. Research progresses of drug delivery material in the treatment of osteoarticular tuberculosis[J]. Chinese Journal of Antituberculosis, 2013, 35(5): 376-378.

参考文献

［1］World Health Organization. Global tuberculosis control report 2012.Geneva:WHO,2012［2012-12-08］.http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf.
［2］吴启秋.对骨关节结核手术适应证的认识.结核病与胸部肿瘤，1998,（2）：1-3.
［3］戈朝晖，王自立，魏敏吉. 脊柱结核病灶中抗痨药物浓度的测定.中华骨科杂志，2004,25(2),97-101.
［4］Lloyd AW. Interfacial bioengineering to enhance surface biocompatibility. Med Device Technol,2002,13(1):18-21.
［5］Buchholz HW, Engelbrecht H. Depot effects of various anti-biotics mixed with Palacos resins.Chirurg,1970,41(11): 511-515.
［6］牛惠生,李怀芬,叶文忠,等.缓释植入型抗结核药异烟肼明胶海绵的实验研究.天津药学，1992,4（3）：7-10.
［7］孟晓林，时和同. 缓释抗结核药佐治脊柱结核合并巨大冷脓肿. 蚌埠医学院学报，2001，26（2）：148.
［8］Fujibayashi S, Senaha Y, Yoshihara S,et al. Long-term follow-up study of bioactive bone cement for repairing a segmental defect in a canine femur.J Long Term Eff Med Implants,2001,11(1/2):93-103.
［9］陈安民，孙淑珍.利福平—陶瓷人工骨核（R-PHA）治疗骨结核的实验研究与临床应用.中华骨科杂志，1992,12(1):18-22.
［10］秦世炳，董伟杰，范俊,等. 医用硫酸钙颗粒在骨关节结核治疗中的应用探讨. 结核病与胸部肿瘤,2006,（2）：103-106.
［11］Hsu YY，Gresser JD，Stewart RR，et al.Mechanisms of isoniazid release from poly(d,1-laetide-co-glycoliole)matrics prepared by dry-mixing and low density polymeric foam methods.J Pharm Sci,1996, 85(7):706-713.
［12］Kailasam S，Daneluzzi D，Gangadharam PR.Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer.Tuber Lung Dis,1994,75(5):361-365.
［13］李大伟, 马远征，杨飞，等.β-磷酸三钙/聚乳酸-聚羟基乙酸/异烟肼缓释材料制备与分析.中国防痨杂志，2013，35（5）：309-313.
［14］张宏其，高琪乐，郭虎兵,等. 人同种异体骨载异烟肼-壳聚糖缓释微球的制备和体内外释药特性. 中国组织工程研究，2012，16(3):479-483.

[1]	杨军, 邓强, 李军杰, 王雨榕, 杜健强, 陈博, 张丽娟. 局部载药缓释系统在脊柱结核中应用的研究进展[J]. 中国防痨杂志, 2023, 45(7): 707-713.
[2]	李大伟马远征杨飞崔旭李力韬安晋宇张嘉利. β-磷酸三钙/聚乳酸-聚羟基乙酸/异烟肼缓释材料制备与分析[J]. 中国防痨杂志, 2013, 35(5): 309-313.